Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.

PHASE2RecruitingINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

July 3, 2024

Primary Completion Date

August 1, 2026

Study Completion Date

December 1, 2026

Conditions

Soft Tissue Sarcoma

Interventions

DRUG

Mitoxantrone Hydrochloride Liposome+Irinotecan+Vincristine

Mitoxantrone hydrochloride liposome will be administered by an intravenous infusion , 4 cycles.

DRUG

Temozolomide+Irinotecan+Vincristine

Q3W, 4 cycles

Trial Locations (1)

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Yizhuo Zhang

OTHER